Back to Search
Start Over
A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer’s disease
- Source :
- Translational Neurodegeneration, Vol 12, Iss 1, Pp 1-4 (2023)
- Publication Year :
- 2023
- Publisher :
- BMC, 2023.
-
Abstract
- Trial registration ClinicalTrials.gov Identifier: NCT05821153, Registered April 20 2023, Retrospectively registered, https://classic.clinicaltrials.gov/ct2/show/NCT05821153
- Subjects :
- Neurology. Diseases of the nervous system
RC346-429
Subjects
Details
- Language :
- English
- ISSN :
- 20479158
- Volume :
- 12
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- Translational Neurodegeneration
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.8a0ebe6290e4359b7e72393eaf523ef
- Document Type :
- article
- Full Text :
- https://doi.org/10.1186/s40035-023-00387-5